BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12350364)

  • 1. Thalidomide treatment in multiple myeloma.
    Strasser K; Ludwig H
    Blood Rev; 2002 Dec; 16(4):207-15. PubMed ID: 12350364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease.
    Rajkumar SV
    Semin Hematol; 2003 Oct; 40(4 Suppl 4):17-22. PubMed ID: 15015892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States.
    Dimopoulos MA; Anagnostopoulos A
    Semin Hematol; 2003 Oct; 40(4 Suppl 4):8-16. PubMed ID: 15015891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma.
    Alexanian R; Weber D; Anagnostopoulos A; Delasalle K; Wang M; Rankin K
    Semin Hematol; 2003 Oct; 40(4 Suppl 4):3-7. PubMed ID: 15015890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in multiple myeloma: past, present and future.
    Harousseau JL
    Future Oncol; 2006 Oct; 2(5):577-89. PubMed ID: 17026450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose thalidomide in myeloma: efficacy and biologic significance.
    Durie BG
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):34-8. PubMed ID: 12520483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunomodulatory drugs in multiple myeloma.
    Anderson KC
    Semin Hematol; 2003 Oct; 40(4 Suppl 4):23-32. PubMed ID: 15015893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide in multiple myeloma: current status and future prospects.
    Cavenagh JD; Oakervee H;
    Br J Haematol; 2003 Jan; 120(1):18-26. PubMed ID: 12492572
    [No Abstract]   [Full Text] [Related]  

  • 10. The current status of thalidomide in the management of multiple myeloma.
    Glasmacher A; von Lilienfeld-Toal M
    Acta Haematol; 2005; 114 Suppl 1():3-7. PubMed ID: 16166765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide alone or with dexamethasone for previously untreated multiple myeloma.
    Weber D; Rankin K; Gavino M; Delasalle K; Alexanian R
    J Clin Oncol; 2003 Jan; 21(1):16-9. PubMed ID: 12506164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide and lenalidomide in the treatment of multiple myeloma.
    Kumar S; Rajkumar SV
    Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X; Aulagner G; Facon T
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide in the management of multiple myeloma.
    Barlogie B; Zangari M; Spencer T; Fassas A; Anaissie E; Badros A; Cromer J; Tricot G
    Semin Hematol; 2001 Jul; 38(3):250-9. PubMed ID: 11486313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide and thalidomide: mechanisms of action--similarities and differences.
    Anderson KC
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S3-8. PubMed ID: 16344099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in the treatment of multiple myeloma.
    Kastritis E; Dimopoulos MA
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):681-99. PubMed ID: 18070713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thalidomide: mechanisms of action and new insights in hematology].
    Leleu X; Micol JB; Guieze R; Berthon C; Kuhnovsky F; Terriou L; Moreau AS; Yakoub-Agha I; Bauters F; Facon T
    Rev Med Interne; 2005 Feb; 26(2):119-27. PubMed ID: 15710258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunomodulatory compounds in multiple myeloma.
    Saini N; Mahindra A
    Expert Opin Investig Drugs; 2013 Feb; 22(2):207-15. PubMed ID: 23265189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in multiple myeloma.
    Rajkumar SV
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.
    Mark TM; Coleman M; Niesvizky R
    Leuk Res; 2014 May; 38(5):517-24. PubMed ID: 24690110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.